Hiperinsulinismo en un lactante mayor

Agrela, Ana María; Moreno, Martha; Espinette, Teresa; León, María; Castillo, Mery; Leyba, Amadeo.
Bol. Hosp. Niños J. M. de los Ríos ; 35(2): 49-53, mayo-ago. 1999. tab
Artículo en Español | LILACS | ID: lil-305180

Documentos relacionados

  1. 50 Years Ago in TheJournalofPediatrics: Diazoxide-Induced Hyperosmolar Nonketotic Coma: Contemporary Genetic Insights.
  2. Higher C-peptide levels and glucose requirements may identify neonates with transient hyperinsulinism hypoglycemia who will benefit from diazoxide treatment.
  3. Palliative treatment of hyperinsulinism with cyproheptadine and diazoxide.
  4. Hyperinsulinaemic hypoglycaemia in deoxyguanosine kinase deficiency.
  5. Rate of Serious Adverse Events Associated with Diazoxide Treatment of Patients with Hyperinsulinism.
  6. Commentary on studies investigating low-dose diazoxide in hyperinsulinism.
  7. Safety and tolerability of diazoxide in Japanese patients with hyperinsulinemic hypoglycemia.
  8. Liver injury may increase the risk of diazoxide toxicity: a case report.
  9. A pilot study: effects of decreasing serum insulin with diazoxide on vitamin D levels in obese women with polycystic ovary syndrome.
  10. Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome.